{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-020785","form_type":"8-K","ticker":"EUDA","cik":"0001847846","company_name":"EUDA Health Holdings Ltd","filed_at":"2023-06-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:41.198917+00:00","generated_at":"2026-06-14T04:16:19.356159+00:00","sec_items":["1.01","1.02","3.02","5.02","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"EUDA amends prepaid forwards, issues 1.6M shares; adjusts CEO settlement to $1.47/share","bullets":["Supplemental Agreement with CEO Dr. Kelvin Chen: 578,439 shares at $1.47/share to settle $850k loan; 271,867 shares forfeited.","Prepaid Forward Agreements accelerated as of June 8, 2023; each seller gets 800,000 shares (1.6M total) immediately due.","Sellers cannot sell more than 15% of daily trading volume; registration rights granted.","Alfred Lim appointed Executive Director effective June 6; resigns from Audit, Comp, and Nominating committees.","Board committees restructured; Audit Committee now Rajpal (chair), Lew, Wong."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-020785","json":"https://secwatch.observer/filing/0001493152-23-020785.json","markdown":"https://secwatch.observer/filing/0001493152-23-020785.md","text":"https://secwatch.observer/filing/0001493152-23-020785.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1847846/000149315223020785/0001493152-23-020785-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1847846/000149315223020785/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T04:16:19.356159+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c287ae9853","claim":"Alfred Lim was appointed as Executive Director at EUDA Health Holdings Ltd.","evidence_excerpt":"On June 6, 2023, the Board of Directors of the Company (the “ Board ”) appointed an incumbent director, Alfred Lim, as the Company’s Executive Director, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1847846/000149315223020785/0001493152-23-020785-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Executive Director"}],"fact_type":"executive_change"},{"claim_id":"1a60647cb29038ab0f4ac5cf4f565e2c2a7c07a7","claim":"EUDA Health Holdings Ltd entered into Supplemental Agreement with Dr. Kelvin Chen valued at 578,439 ordinary shares at $1.47 per share (effective 2023-06-06).","evidence_excerpt":"Pursuant to the Supplemental Agreement, Dr. Chen has agreed to release and discharge KRHSG of all claims in return for 578,439 ordinary shares at $1.47 per share, the closing bid price of EUDA ordinary shares on May 15, 2023.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1847846/000149315223020785/0001493152-23-020785-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"settlement"},{"label":"Counterparty","value":"Dr. Kelvin Chen"},{"label":"Value","value":"578,439 ordinary shares at $1.47 per share"},{"label":"Effective","value":"2023-06-06"}],"fact_type":"material_agreement"},{"claim_id":"d66425a5140a2ac4a0533c70aeceaa30de21e1c3","claim":"EUDA Health Holdings Ltd amended Amendments to Prepaid Forward Agreements with the Sellers valued at Amended Maturity Consideration to 800,000 ordinary shares per Seller; acceleration of maturity; regi (effective 2023-06-08).","evidence_excerpt":"On June 8, 2023, EUDA and the Sellers entered into amendments to the Prepaid Forward Agreements (together, the “Amendments”), to amend the definition of “Maturity Consideration,” such that, Maturity Consideration shall consist of 800,000 ordinary shares of EUDA to be issued to the each Seller by EUDA.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1847846/000149315223020785/0001493152-23-020785-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"the Sellers"},{"label":"Value","value":"Amended Maturity Consideration to 800,000 ordinary shares per Seller; acceleration of maturity; regi"},{"label":"Effective","value":"2023-06-08"}],"fact_type":"material_agreement"},{"claim_id":"df8206646715cf47f53e3146e1fb100862a44dd3","claim":"EUDA Health Holdings Ltd terminated Prepaid Forward Agreements with the Sellers valued at Prepaid Forward Transactions accelerated; 1,600,000 ordinary shares due and payable; no further fees (effective 2023-06-08).","evidence_excerpt":"Pursuant to the Amendments, the parties agreed that the Prepaid Forward Transactions shall be accelerated as of the date of the Amendments, and accordingly, the 800,000 ordinary shares (or 1,600,000 ordinary shares in the aggregate), became immediately due and payable to the Sellers upon execution of the Amendments.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1847846/000149315223020785/0001493152-23-020785-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"termination"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"the Sellers"},{"label":"Value","value":"Prepaid Forward Transactions accelerated; 1,600,000 ordinary shares due and payable; no further fees"},{"label":"Effective","value":"2023-06-08"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}